Last reviewed · How we verify

NCT04084093

Evaluating the Use of a Concentrated Surfactant Gel in Burn Patients

Withdrawn NA Last updated 20 April 2020
What this trial tests

NA trial testing Surfactant Gel in Burns. Withdrawn.

Timeline
12 February 2020
Primary endpoint
8 April 2020
8 April 2020

Quick facts

Lead sponsorMedline Industries
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date12 February 2020
Primary completion8 April 2020
Estimated completion8 April 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medline Industries — full company profile →

Who can join

18 and older, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be an observational study evaluating subject's perception of pain to dressing changes during removal and application of a surfactant gel. Wound healing will also be monitored. Anxiety before dressing change will be measured using a burn specific pain anxiety scale. Study intervention will include cleansing the wound per the facility's standard of care, followed by applying the investigational product on the wound. This will be followed by placing an appropriate secondary dressing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Medline Industries trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04084093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing